Skip to content

Psilocybin research published in 2014

20 studies whose primary subject is psilocybin were published in 2014, down from 22 in 2013. Newest first. Back to the psilocybin overview

Studies

Recreational Use, Analysis and Toxicity of Tryptamines

Current Neuropharmacology December 10, 2014 Roberta Tittarelli, Giulio Mannocchi, Flaminia Pantano et al. 217 citations

Information from Internet and from published scientific literature, organized in the way we proposed in this review, provides an effective tool for specialists facing the emerging NPS threat to public health and public security, including the personnel working in Emergency Department.

Phylogenetic and chemical studies in the potential psychotropic species complex of Psilocybe atrobrunnea with taxonomic and nomenclatural notes

Persoonia - Molecular Phylogeny and Evolution of Fungi November 26, 2014 Jan Borovička, Miroslav Obornı́k, J Strĭbrný et al. 30 citations

Five Psilocybe species with unresolved systematic position ( P. atrobrunnea , P. laetissima , P. medul- losa , P. pelliculosa , and P. silvatica ) were investigated using four molecular markers (EF1-α, ITS, LSU, and IGS). Phylogenetic analysis revealed that with the exception of P. laetissima , which is now rightfully classified in the genus Leratiomyces , all investigated species belong to...

The effect of particular active substances of hallucinogenic mushrooms

Acta Universitatis Lodziensis Folia Biologica et Oecologica November 26, 2014 Marek Wieczorek 4 citations

Magic mushrooms have accompanied man for thousands of years. Formerly they were used for religious and culture purposes. Those fungi belong mainly to the genera Conocybe, Copelandia, Panaeolus, Psilocybe and Stropharia. A number of these fungal species produce substances, like psilocybin, psilocin, ibotenic acid or muscimol. Because of their chemical similarity to naturally occurring...

Pholiotina cyanopus, a rare fungus producingpsychoactive tryptamines

Open Life Sciences November 19, 2014 Marek Halama, Anna Poliwoda, Іzabela Jasicka-Misiak et al.

Abstract Pholiotina cyanopus was collected from wood chips and other woody remnants of undetermined tree species. Its basidiomata were found in June within the area of closed sawmill in the central part of Żywiec city (SW Poland). Description and illustration of Ph. cyanopus based on Polish specimens are provided and its ecology, general distribution and comparison with similar taxa –...

DOI: 10.1515/biol-2015-0005 (opens in new tab) Psilocybin Basidiocarp Tryptamines Dry weight +1

Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats

Biological and Pharmaceutical Bulletin October 23, 2014 Yuichi Sakashita, Kenji Abe, N. Katagiri et al. 84 citations

Psilocin (3-[2-(dimethylamino)ethyl]-1H-indol-4-ol) is a hallucinogenic component of the Mexican mushroom Psilocybe mexicana and a skeletal serotonin (5-HT) analogue. Psilocin is the active metabolite of psilocybin (3-[2-(dimethylamino)ethyl]-1H-indol-4-yl dihydrogen phosphate). In the present study, we examined the effects of systemically administered psilocin on extracellular dopamine and...

DOI: 10.1248/bpb.b14-00315 (opens in new tab) Serotonin Nucleus accumbens Dopaminergic Microdialysis +4

Psilocybin and Obsessive Compulsive Disorder

Journal of Psychoactive Drugs October 20, 2014 James A. Wilcox 55 citations

Obsessive Compulsive Disorder (OCD) is a psychiatric disorder with considerable morbidity and mortality. This condition disables many individuals and is often refractory to treatment. Research suggests that serotonin plays a role in OCD symptom reduction. We present a case of an individual who successfully used psilocybin, a serotonergic agent, to reduce the core symptoms of OCD for several...

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

Journal of Psychopharmacology September 11, 2014 Mary P Cosimano, Matthew W. Johnson, Albert Garcia‐romeu et al. 910 citations

Despite suggestive early findings on the therapeutic use of hallucinogens in the treatment of substance use disorders, rigorous follow-up has not been conducted. To determine the safety and feasibility of psilocybin as an adjunct to tobacco smoking cessation treatment we conducted an open-label pilot study administering moderate (20 mg/70 kg) and high (30 mg/70 kg) doses of psilocybin within a...

ENTHEOGENS, MYSTICISM, AND NEUROSCIENCE

Zygon: Journal of Religion and Science August 26, 2014 Ron Cole-Turner 11 citations

Entheogens or psychedelic drugs such as lysergic acid diethylamide (LSD) and psilocybin are associated with mystical states of experience. Drug laws currently limit research, but important new work is under way at major biomedical research facilities showing that entheogens reliably occasion mystical experiences and thereby allow research into brain states during these experiences. Are...

Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.

Therapeutic Advances in Psychopharmacology August 1, 2014 David Baumeister, Georgina Barnes, Giovanni Giaroli et al.

Hallucinogens have been part of spiritual practice for millennia, but controversy surrounding their mind-manifesting effects led to their proscription by the mid-20th century, largely without evidence of harm or toxicity and despite nascent data suggesting therapeutic utility in treating depressive illnesses. This review explores their pharmacodynamic actions and the current limited data on...

14C-Psilocin tissue distribution in pregnant rats after intravenous administration

Functional Foods in Health and Disease July 27, 2014 F. C. P. Law, Grace K. Poon, Y. C. Chui et al. 11 citations

Background: Many species of hallucinogenic mushrooms have been found in the genus Psilocybe. The main psychoactive chemicals of Psilocybe mushrooms are psilocin and its phosphoryloxy derivative, psilocybin. In addition to its psychedelic effects, psilocybin is an effective agent to lift the mood of depressed patients with terminal cancers.Objective: To study the dispositional kinetics of...

DOI: 10.31989/ffhd.v4i6.9 (opens in new tab) Psilocybin Urine Metabolite Pharmacology +2

Does the Nervous System Have an Intrinsic Archaic Language? Entoptic Images and Phosphenes

NeuroQuantology June 2, 2014 H. Umit Sayin 7 citations

Psychoactive plants have been consumed by many cultures, cults and groups during religious rituals and ceremonies for centuries and they have been influential on the eruption of the many images, secret and religious symbols, esoteric geometrical shapes, archetypes, religious figures, philosophy of religions since the dawn of Homo sapiens. Some of the psychoactive plants used for religious...

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers

Frontiers in Human Neuroscience May 27, 2014 Leor Roseman, Robert Leech, Amanda Feilding et al. 293 citations

Perturbing a system and observing the consequences is a classic scientific strategy for understanding a phenomenon. Psychedelic drugs perturb consciousness in a marked and novel way and thus are powerful tools for studying its mechanisms. In the present analysis, we measured changes in resting-state functional connectivity (RSFC) between a standard template of different independent components...

Psychedelics, Glutamate, and Neuroimaging Studies

Anesthesiology May 21, 2014 Rafael G. Dos Santos 1 citation

The article by Icaza and Mashour1 is a very interesting article because it presents a topic of investigation that is currently attracting the attention of pharmacologists, neuroscientists, and biological psychiatrists around the globe: human research with psychedelic compounds. The text brings important information regarding the history and pharmacology of psychedelics but presents important...

The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the Rat

Frontiers in Behavioral Neuroscience May 16, 2014 Lukáš Rambousek, Tomáš Páleníček, Karel Valeš et al. 55 citations

The involvement of the serotonin system in the pathophysiology of schizophrenia has been elucidated by experiments with hallucinogens. Application of a hallucinogen to humans leads to changes in perception, cognition, emotions, and induction of psychotic-like symptoms that resemble symptoms of schizophrenia. In rodent studies, their acute administration affects sensorimotor gating, locomotor...

DOI: 10.3389/fnbeh.2014.00180 (opens in new tab) Hallucinogen Memory consolidation Water maze Cognition +2

Chapter 51. Hallucinogen-Related Disorders

American Psychiatric Publishing eBooks May 5, 2014 Robert N. Pechnick, Kathryn A. Cunningham, Itai Danovitch

The hallucinogens are a class of psychoactive drugs, either synthetic or plant products, that produce auditory and/or visual hallucinations as well as thought, mood, and perceptual changes. Depending on dosage, expectation (set), and environment (setting), they also can induce euphoria and a state similar to a transcendental experience. These hallucinations can be present as part of a delirium...

Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers

Biological Psychiatry April 26, 2014 Rainer Kraehenmann, Katrin H. Preller, Milan Scheidegger et al. 325 citations

BackgroundThe amygdala is a key structure in serotonergic emotion-processing circuits. In healthy volunteers, acute administration of the serotonin 1A/2A/2C receptor agonist psilocybin reduces neural responses to negative stimuli and induces mood changes toward positive states. However, it is little-known whether psilocybin reduces amygdala reactivity to negative stimuli and whether any change...

Quantitative Phosphoproteomics Unravels Biased Phosphorylation of Serotonin 2A Receptor at Ser280 by Hallucinogenic versus Nonhallucinogenic Agonists

Molecular & Cellular Proteomics March 18, 2014 Samah Karaki, Carine Bécamel, Samy Murat et al. 73 citations

The serotonin 5-HT(2A) receptor is a primary target of psychedelic hallucinogens such as lysergic acid diethylamine, mescaline, and psilocybin, which reproduce some of the core symptoms of schizophrenia. An incompletely resolved paradox is that only some 5-HT(2A) receptor agonists exhibit hallucinogenic activity, whereas structurally related agonists with comparable affinity and activity lack...

Seeking the Sacred with Psychoactive Substances

2014 9 citations

Can drugs be used intelligently and responsibly to expand human consciousness and heighten spirituality? This two-volume work presents objective scientific information and personal stories aiming to answer the question. The first of its kind, this intriguing two-volume set objectively reports on and assesses this modern psycho-social movement in world culture: the constructive medical use of...

The Heffter Research Institute: Past and Hopeful Future

Journal of Psychoactive Drugs 2014 David E. Nichols 24 citations

This essay describes the founding of the Heffter Research Institute in 1993 and its development up to the present. The Institute is the only scientific research organization dedicated to scientific research into the medical value of psychedelics, and it has particularly focused on the use of psilocybin. The first clinical treatment study was of the value of psilocybin in obsessive-compulsive...